Skip to main content

Advertisement

Open Peer Review Reports for: Additional hepatic 166 Ho-radioembolization in patients with neuroendocrine tumours treated with 177 Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
23 Jan 2017 Submitted Original manuscript
6 Aug 2017 Author responded Author comments - Arthur Braat
Resubmission - Version 2
6 Aug 2017 Submitted Manuscript version 2
17 Aug 2017 Reviewed Reviewer Report - Douglas Coldwell
29 Oct 2017 Reviewed Reviewer Report - Steven Colquhoun
28 Nov 2017 Reviewed Reviewer Report - Julius Chapiro
22 Jan 2018 Author responded Author comments - Arthur Braat
Resubmission - Version 3
22 Jan 2018 Submitted Manuscript version 3
12 Mar 2018 Reviewed Reviewer Report - Julius Chapiro
15 May 2018 Author responded Author comments - Arthur Braat
Resubmission - Version 4
15 May 2018 Submitted Manuscript version 4
4 Jun 2018 Author responded Author comments - Arthur Braat
Resubmission - Version 5
4 Jun 2018 Submitted Manuscript version 5
Publishing
5 Jun 2018 Editorially accepted
15 Jun 2018 Article published 10.1186/s12876-018-0817-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement